Cambridge, MA-based Constellation Pharmaceuticals Raises $17 Million More. See their jobs
From New England Tech Wire | Aug 17, 2009
Cambridge, Mass. -- Constellation Pharmaceuticals, a
Cambridge-based biopharmaceutical company, announced on Thursday that it has
raised an additional $17 million in its first round of venture capital, bringing
the total raised so far to $32 million. Investors in the deal include Third
Rock Ventures, The Column Group, Venrock, and Altitude Life Science
Ventures. Constellation also announced on Thursday that it has hired Mark A.
Goldsmith as its CEO. Until recently, Goldsmith was senior
executive-in-residence at Prospect Venture Partners, a healthcare venture
capital firm. Constellation is focused on discovering and developing new drugs
targeting epigenetic regulation of the human genome.
http://www.constellationpharma.com
View Constellation Pharma Jobs
Note: at posting time there were jobs for 2 scientists only. But that could change. What could be in the stars with $17M in additional funding?
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| Be Self-Employed Writing Content | 0 | 0 | 292 | ||
| Work from Home Writing Articles | 0 | 0 | 120 | ||
| Band Together Seeks New Executive Director in Raleigh Area | 0 | 0 | 525 |